Drug Profile
Research programme: urokinase plasminogen activator inhibitors - Dendreon
Alternative Names: U-PA antagonists research programme - Dendreon; Urokinase plasminogen activator inhibitors research programme - DendreonLatest Information Update: 16 May 2007
Price :
$50
*
At a glance
- Originator Dendreon Corporation
- Class Monoclonal antibodies
- Mechanism of Action Plasminogen activator inhibitor-1 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 05 Jan 2004 The activities of Dendreon San Diego LLC are being relocated to Dendreon's Seattle headquarters
- 04 Aug 2003 Corvas International has been acquired by Dendreon Corporation and is now called Dendreon San Diego LLC
- 12 Sep 2002 This programme is still in active development